Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response
Wojciech Barczak(University of Oxford), Nicholas B. La Thangue(Northeast Catholic College)
Cited by 115
Related Papers
HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
|Immunology and Cell Biology|2011|443
Atypical E2F activity restrains APC/C <sup>CCS52A2</sup> function obligatory for endocycle onset
|Proceedings of the National Academy of Sciences|2008|183
TLR Adaptor Protein MYD88 Mediates Sensitivity to HDAC Inhibitors via a Cytokine-Dependent Mechanism
|Cancer Research|2016|44
hTERT gene knockdown enhances response to radio- and chemotherapy in head and neck cancer cell lines through a DNA damage pathway modification
|Scientific Reports|2018|16
The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity
|Communications Biology|2023|16